Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Autophagy | 22 | 2021 | 148 | 6.470 |
Why?
|
Retinoblastoma Protein | 12 | 2010 | 66 | 2.730 |
Why?
|
Microtubule-Associated Proteins | 7 | 2021 | 176 | 2.610 |
Why?
|
Membrane Proteins | 10 | 2021 | 1194 | 2.550 |
Why?
|
Mitochondrial Proteins | 7 | 2021 | 123 | 2.390 |
Why?
|
Neoplasms | 13 | 2021 | 2889 | 2.090 |
Why?
|
Mitochondria | 8 | 2021 | 535 | 2.090 |
Why?
|
Proto-Oncogene Proteins | 8 | 2021 | 645 | 1.920 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 415 | 1.170 |
Why?
|
Cell Movement | 4 | 2018 | 756 | 1.110 |
Why?
|
Focal Adhesions | 2 | 2016 | 69 | 1.080 |
Why?
|
Neoplasm Metastasis | 9 | 2021 | 1056 | 1.070 |
Why?
|
Lipid Metabolism | 2 | 2019 | 196 | 1.030 |
Why?
|
Genes, Retinoblastoma | 7 | 2010 | 22 | 1.020 |
Why?
|
Carcinogenesis | 3 | 2021 | 194 | 0.970 |
Why?
|
Neoplastic Stem Cells | 4 | 2019 | 143 | 0.900 |
Why?
|
Animals | 53 | 2023 | 26518 | 0.890 |
Why?
|
Autophagy-Related Protein-1 Homolog | 1 | 2021 | 3 | 0.840 |
Why?
|
Erythroblasts | 5 | 2007 | 25 | 0.840 |
Why?
|
Cell Cycle | 10 | 2016 | 502 | 0.800 |
Why?
|
DNA Damage | 7 | 2017 | 362 | 0.800 |
Why?
|
Mice | 34 | 2023 | 11313 | 0.770 |
Why?
|
ras Proteins | 2 | 2019 | 128 | 0.750 |
Why?
|
Erythropoiesis | 6 | 2007 | 52 | 0.740 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 378 | 0.700 |
Why?
|
Paxillin | 2 | 2016 | 59 | 0.700 |
Why?
|
Genes, Tumor Suppressor | 2 | 2014 | 157 | 0.690 |
Why?
|
Neurodegenerative Diseases | 2 | 2016 | 43 | 0.650 |
Why?
|
Mitochondria, Liver | 3 | 2021 | 27 | 0.650 |
Why?
|
Hematopoiesis | 3 | 2008 | 163 | 0.650 |
Why?
|
Liver | 3 | 2021 | 1229 | 0.640 |
Why?
|
Homeostasis | 6 | 2021 | 408 | 0.620 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2016 | 69 | 0.620 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2015 | 124 | 0.620 |
Why?
|
Inflammation | 3 | 2017 | 913 | 0.590 |
Why?
|
Triple Negative Breast Neoplasms | 2 | 2017 | 136 | 0.580 |
Why?
|
Muscular Atrophy | 1 | 2016 | 38 | 0.570 |
Why?
|
src-Family Kinases | 1 | 2016 | 74 | 0.560 |
Why?
|
Metabolic Diseases | 1 | 2016 | 48 | 0.560 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2019 | 589 | 0.550 |
Why?
|
Oxidative Stress | 4 | 2017 | 446 | 0.530 |
Why?
|
Macrophages | 3 | 2007 | 554 | 0.510 |
Why?
|
Humans | 44 | 2021 | 86281 | 0.490 |
Why?
|
Tumor Suppressor Proteins | 4 | 2021 | 279 | 0.470 |
Why?
|
Cell Line, Tumor | 10 | 2023 | 2421 | 0.470 |
Why?
|
Fibroblasts | 2 | 2014 | 729 | 0.460 |
Why?
|
Flow Cytometry | 3 | 2010 | 679 | 0.460 |
Why?
|
Mice, Knockout | 10 | 2021 | 1918 | 0.450 |
Why?
|
Signal Transduction | 10 | 2021 | 3233 | 0.430 |
Why?
|
Hypoxia | 2 | 2007 | 638 | 0.420 |
Why?
|
Cells, Cultured | 8 | 2021 | 2810 | 0.400 |
Why?
|
Phagosomes | 2 | 2010 | 39 | 0.390 |
Why?
|
Carcinoma | 1 | 2014 | 434 | 0.370 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 108 | 0.370 |
Why?
|
Cell Differentiation | 8 | 2007 | 1456 | 0.370 |
Why?
|
Mice, Transgenic | 6 | 2021 | 1537 | 0.350 |
Why?
|
Erythrocytes | 5 | 2007 | 255 | 0.350 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2009 | 46 | 0.350 |
Why?
|
Gene Expression Regulation | 9 | 2021 | 1917 | 0.350 |
Why?
|
Mitochondrial Dynamics | 2 | 2021 | 53 | 0.340 |
Why?
|
Phosphorylation | 3 | 2021 | 1101 | 0.340 |
Why?
|
Apoptosis | 8 | 2010 | 1678 | 0.330 |
Why?
|
E2F Transcription Factors | 2 | 2007 | 19 | 0.320 |
Why?
|
E2F2 Transcription Factor | 1 | 2007 | 4 | 0.320 |
Why?
|
Mammary Glands, Animal | 3 | 2018 | 78 | 0.310 |
Why?
|
Models, Biological | 7 | 2016 | 1748 | 0.300 |
Why?
|
Cell Adhesion | 3 | 2018 | 418 | 0.290 |
Why?
|
Biological Assay | 3 | 2021 | 78 | 0.290 |
Why?
|
Cell Communication | 1 | 2007 | 194 | 0.290 |
Why?
|
Amino Acid Motifs | 2 | 2016 | 116 | 0.280 |
Why?
|
Breast Neoplasms | 3 | 2018 | 2881 | 0.280 |
Why?
|
Aging | 2 | 2016 | 689 | 0.280 |
Why?
|
Cyclins | 2 | 1996 | 82 | 0.280 |
Why?
|
Carrier Proteins | 3 | 2018 | 672 | 0.270 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 645 | 0.270 |
Why?
|
Myelopoiesis | 1 | 2005 | 10 | 0.260 |
Why?
|
Stress, Physiological | 2 | 2017 | 226 | 0.260 |
Why?
|
MAP Kinase Kinase 4 | 3 | 2011 | 67 | 0.260 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2019 | 1196 | 0.260 |
Why?
|
Cell Proliferation | 4 | 2017 | 1571 | 0.250 |
Why?
|
Antineoplastic Agents | 4 | 2019 | 2351 | 0.240 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2015 | 427 | 0.240 |
Why?
|
Cell Nucleus | 5 | 2017 | 579 | 0.230 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2019 | 153 | 0.220 |
Why?
|
Prostatic Neoplasms | 2 | 2011 | 1708 | 0.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2015 | 302 | 0.220 |
Why?
|
Promoter Regions, Genetic | 6 | 2017 | 937 | 0.220 |
Why?
|
HEK293 Cells | 2 | 2021 | 615 | 0.210 |
Why?
|
Disease Models, Animal | 2 | 2019 | 2227 | 0.210 |
Why?
|
Protein Binding | 4 | 2017 | 1454 | 0.210 |
Why?
|
Blotting, Western | 3 | 2015 | 781 | 0.200 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2021 | 99 | 0.200 |
Why?
|
Reactive Oxygen Species | 3 | 2015 | 480 | 0.200 |
Why?
|
Autophagosomes | 2 | 2021 | 3 | 0.190 |
Why?
|
Glucagon | 1 | 2021 | 111 | 0.190 |
Why?
|
Autophagy-Related Proteins | 2 | 2021 | 20 | 0.190 |
Why?
|
Cytosol | 1 | 2021 | 189 | 0.190 |
Why?
|
Disease Susceptibility | 1 | 2021 | 192 | 0.190 |
Why?
|
Genes, p53 | 2 | 1999 | 109 | 0.180 |
Why?
|
Autophagy-Related Protein 7 | 2 | 2017 | 12 | 0.180 |
Why?
|
Genome, Mitochondrial | 1 | 2019 | 26 | 0.180 |
Why?
|
Adenosine Triphosphate | 2 | 2012 | 314 | 0.180 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2019 | 14 | 0.180 |
Why?
|
Cell Death | 4 | 2008 | 256 | 0.170 |
Why?
|
Cancer-Associated Fibroblasts | 1 | 2019 | 36 | 0.170 |
Why?
|
DNA, Mitochondrial | 1 | 2019 | 183 | 0.170 |
Why?
|
Base Sequence | 10 | 2017 | 2329 | 0.170 |
Why?
|
Point Mutation | 1 | 2019 | 246 | 0.170 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 551 | 0.170 |
Why?
|
Immunohistochemistry | 3 | 2015 | 1752 | 0.170 |
Why?
|
Glycolysis | 2 | 2019 | 129 | 0.170 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2017 | 380 | 0.160 |
Why?
|
Thiolester Hydrolases | 1 | 2018 | 14 | 0.160 |
Why?
|
Sequestosome-1 Protein | 2 | 2015 | 22 | 0.160 |
Why?
|
Globins | 5 | 1991 | 31 | 0.160 |
Why?
|
Embryo, Mammalian | 4 | 2004 | 207 | 0.150 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2017 | 85 | 0.150 |
Why?
|
Genetic Therapy | 1 | 2019 | 342 | 0.150 |
Why?
|
RNA, Messenger | 2 | 2021 | 1975 | 0.150 |
Why?
|
Disease Progression | 3 | 2015 | 1531 | 0.150 |
Why?
|
Neoplasms, Experimental | 1 | 1999 | 269 | 0.150 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 78 | 0.150 |
Why?
|
Anoikis | 1 | 2016 | 7 | 0.150 |
Why?
|
Immunologic Surveillance | 1 | 2016 | 14 | 0.150 |
Why?
|
Protein Transport | 2 | 2016 | 410 | 0.140 |
Why?
|
Protein Interaction Maps | 1 | 2016 | 48 | 0.140 |
Why?
|
Fluorescent Dyes | 1 | 2018 | 242 | 0.140 |
Why?
|
Adaptation, Biological | 1 | 2017 | 85 | 0.140 |
Why?
|
Tumor Escape | 1 | 2016 | 49 | 0.140 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 182 | 0.140 |
Why?
|
Oxidation-Reduction | 2 | 2019 | 373 | 0.140 |
Why?
|
Protein Stability | 1 | 2016 | 99 | 0.140 |
Why?
|
S Phase | 4 | 2007 | 62 | 0.140 |
Why?
|
Ultraviolet Rays | 1 | 2017 | 193 | 0.140 |
Why?
|
Lysosomes | 2 | 2021 | 104 | 0.140 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2016 | 165 | 0.130 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 234 | 0.130 |
Why?
|
Cytoskeletal Proteins | 1 | 2016 | 222 | 0.130 |
Why?
|
Autophagy-Related Protein 5 | 1 | 2015 | 11 | 0.130 |
Why?
|
Molecular Sequence Data | 8 | 2007 | 3029 | 0.130 |
Why?
|
Carcinoma in Situ | 1 | 2015 | 53 | 0.130 |
Why?
|
Energy Metabolism | 1 | 2017 | 271 | 0.130 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2015 | 54 | 0.130 |
Why?
|
Macrolides | 1 | 2015 | 31 | 0.130 |
Why?
|
Cytoskeleton | 1 | 2016 | 192 | 0.130 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 2062 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 3 | 2015 | 3347 | 0.130 |
Why?
|
Biomarkers | 3 | 2021 | 1709 | 0.120 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 151 | 0.120 |
Why?
|
Adaptation, Physiological | 1 | 2016 | 306 | 0.120 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2014 | 111 | 0.120 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 1047 | 0.120 |
Why?
|
Epithelial Cells | 1 | 2018 | 662 | 0.120 |
Why?
|
Skin | 1 | 2017 | 554 | 0.120 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2014 | 156 | 0.110 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 352 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2008 | 74 | 0.110 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 1992 | 9 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 589 | 0.110 |
Why?
|
E2F1 Transcription Factor | 2 | 2010 | 13 | 0.110 |
Why?
|
Gluconeogenesis | 1 | 2012 | 14 | 0.110 |
Why?
|
Lipogenesis | 1 | 2012 | 22 | 0.110 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 1051 | 0.110 |
Why?
|
Lactams, Macrocyclic | 1 | 2011 | 14 | 0.100 |
Why?
|
Mouth Neoplasms | 1 | 2014 | 194 | 0.100 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2012 | 64 | 0.100 |
Why?
|
Benzoquinones | 1 | 2011 | 27 | 0.100 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2011 | 17 | 0.100 |
Why?
|
Fasting | 1 | 2012 | 161 | 0.100 |
Why?
|
Fatty Acids | 1 | 2012 | 129 | 0.100 |
Why?
|
Microscopy, Fluorescence | 2 | 2010 | 424 | 0.100 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 125 | 0.100 |
Why?
|
Oxygen Consumption | 1 | 2012 | 239 | 0.100 |
Why?
|
Cell Cycle Checkpoints | 1 | 2011 | 63 | 0.100 |
Why?
|
Fatty Liver | 1 | 2012 | 124 | 0.100 |
Why?
|
DNA-Binding Proteins | 6 | 1998 | 1208 | 0.100 |
Why?
|
Orchiectomy | 1 | 2010 | 67 | 0.100 |
Why?
|
Tissue Distribution | 2 | 2005 | 290 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 579 | 0.090 |
Why?
|
Sirolimus | 1 | 2011 | 169 | 0.090 |
Why?
|
Receptors, Androgen | 1 | 2010 | 110 | 0.090 |
Why?
|
Female | 10 | 2019 | 44405 | 0.090 |
Why?
|
Propidium | 1 | 2009 | 7 | 0.090 |
Why?
|
Microscopy, Electron | 1 | 2010 | 502 | 0.090 |
Why?
|
NAD | 1 | 2009 | 65 | 0.090 |
Why?
|
Embryonic and Fetal Development | 2 | 2001 | 72 | 0.090 |
Why?
|
Contrast Media | 1 | 2014 | 1076 | 0.090 |
Why?
|
Gene Expression | 2 | 2014 | 1281 | 0.090 |
Why?
|
Glucose | 1 | 2012 | 637 | 0.090 |
Why?
|
Nucleotides | 1 | 2009 | 95 | 0.090 |
Why?
|
Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2009 | 72 | 0.090 |
Why?
|
Necrosis | 1 | 2009 | 204 | 0.080 |
Why?
|
Mice, Inbred C57BL | 3 | 2012 | 3087 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 24 | 0.080 |
Why?
|
Up-Regulation | 2 | 2008 | 710 | 0.080 |
Why?
|
Cell Survival | 2 | 2007 | 966 | 0.080 |
Why?
|
Tumor Cells, Cultured | 3 | 2018 | 1040 | 0.080 |
Why?
|
Fetal Viability | 1 | 2007 | 9 | 0.080 |
Why?
|
Deferoxamine | 1 | 2007 | 18 | 0.080 |
Why?
|
Eukaryotic Cells | 1 | 2007 | 43 | 0.080 |
Why?
|
Longevity | 1 | 2007 | 51 | 0.080 |
Why?
|
Clinical Laboratory Techniques | 1 | 2007 | 73 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 2267 | 0.080 |
Why?
|
Prognosis | 1 | 2015 | 3669 | 0.080 |
Why?
|
Siderophores | 1 | 2007 | 22 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 166 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 927 | 0.080 |
Why?
|
Erythrocytes, Abnormal | 1 | 2007 | 12 | 0.080 |
Why?
|
Chimera | 2 | 2004 | 56 | 0.080 |
Why?
|
Binding Sites | 4 | 1995 | 1098 | 0.080 |
Why?
|
Integrases | 1 | 2007 | 59 | 0.080 |
Why?
|
Biomarkers, Tumor | 1 | 2015 | 1461 | 0.080 |
Why?
|
Mitosis | 1 | 2007 | 151 | 0.070 |
Why?
|
Transcription Factors | 4 | 1998 | 1555 | 0.070 |
Why?
|
Cisplatin | 1 | 2009 | 612 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2014 | 1075 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2007 | 162 | 0.070 |
Why?
|
Mice, Inbred Strains | 2 | 2004 | 305 | 0.070 |
Why?
|
Sequence Alignment | 1 | 2007 | 351 | 0.070 |
Why?
|
Cell Line | 3 | 2009 | 2466 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 199 | 0.070 |
Why?
|
Placenta | 1 | 2007 | 173 | 0.070 |
Why?
|
Mutation | 4 | 2019 | 3952 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 297 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2015 | 2260 | 0.070 |
Why?
|
U937 Cells | 1 | 2005 | 32 | 0.070 |
Why?
|
Immunoprecipitation | 1 | 2005 | 134 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 689 | 0.060 |
Why?
|
Anemia, Aplastic | 1 | 2004 | 30 | 0.060 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2005 | 90 | 0.060 |
Why?
|
Immunoblotting | 1 | 2005 | 267 | 0.060 |
Why?
|
DNA, Neoplasm | 1 | 2005 | 265 | 0.060 |
Why?
|
Gene Silencing | 1 | 2004 | 172 | 0.060 |
Why?
|
RNA Interference | 2 | 2018 | 368 | 0.060 |
Why?
|
Down-Regulation | 1 | 2005 | 504 | 0.060 |
Why?
|
Lymphoma | 1 | 2005 | 262 | 0.060 |
Why?
|
Male | 4 | 2019 | 40860 | 0.060 |
Why?
|
Arginine | 1 | 2023 | 136 | 0.060 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 736 | 0.060 |
Why?
|
Time Factors | 2 | 2018 | 5198 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 877 | 0.060 |
Why?
|
Protein Biosynthesis | 1 | 2005 | 378 | 0.060 |
Why?
|
Leukemia | 1 | 2005 | 318 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 1073 | 0.050 |
Why?
|
Amino Acids | 1 | 2023 | 252 | 0.050 |
Why?
|
Transcriptional Activation | 2 | 1994 | 280 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2008 | 738 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 1381 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 2434 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2019 | 2699 | 0.050 |
Why?
|
Phenotype | 1 | 2007 | 2375 | 0.050 |
Why?
|
Organ Specificity | 1 | 2021 | 257 | 0.050 |
Why?
|
In Situ Nick-End Labeling | 3 | 2011 | 121 | 0.050 |
Why?
|
Cell Division | 2 | 2008 | 696 | 0.050 |
Why?
|
Genetic Heterogeneity | 1 | 2019 | 62 | 0.050 |
Why?
|
NADP | 1 | 2019 | 45 | 0.040 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 230 | 0.040 |
Why?
|
Brain | 2 | 2001 | 2211 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2019 | 391 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 1200 | 0.040 |
Why?
|
Databases, Genetic | 1 | 2019 | 259 | 0.040 |
Why?
|
Fetal Proteins | 1 | 2018 | 17 | 0.040 |
Why?
|
Acyl Coenzyme A | 1 | 2018 | 17 | 0.040 |
Why?
|
Madin Darby Canine Kidney Cells | 1 | 2018 | 17 | 0.040 |
Why?
|
Fibrillar Collagens | 1 | 2018 | 10 | 0.040 |
Why?
|
A549 Cells | 1 | 2018 | 39 | 0.040 |
Why?
|
Lipoylation | 1 | 2018 | 28 | 0.040 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 480 | 0.040 |
Why?
|
MCF-7 Cells | 1 | 2018 | 106 | 0.040 |
Why?
|
Cell Shape | 1 | 2018 | 50 | 0.040 |
Why?
|
Mice, Nude | 2 | 2011 | 790 | 0.040 |
Why?
|
Hepatocyte Growth Factor | 1 | 2018 | 84 | 0.040 |
Why?
|
Myosins | 1 | 2018 | 88 | 0.040 |
Why?
|
Microscopy, Confocal | 1 | 2018 | 268 | 0.040 |
Why?
|
Molecular Docking Simulation | 1 | 2017 | 46 | 0.040 |
Why?
|
Dogs | 1 | 2018 | 684 | 0.040 |
Why?
|
Peripheral Nervous System | 1 | 1996 | 21 | 0.040 |
Why?
|
Dinoprostone | 1 | 2017 | 69 | 0.040 |
Why?
|
Cellular Microenvironment | 1 | 2017 | 27 | 0.040 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 66 | 0.040 |
Why?
|
Histocytochemistry | 1 | 1996 | 130 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2017 | 78 | 0.040 |
Why?
|
Lymphangiogenesis | 1 | 2017 | 38 | 0.040 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 61 | 0.040 |
Why?
|
Cyclooxygenase 2 | 1 | 2017 | 99 | 0.040 |
Why?
|
HeLa Cells | 1 | 2018 | 498 | 0.040 |
Why?
|
Epidermis | 1 | 2017 | 100 | 0.040 |
Why?
|
Morphogenesis | 1 | 2018 | 188 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 455 | 0.040 |
Why?
|
Capillary Permeability | 1 | 2017 | 130 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2017 | 132 | 0.040 |
Why?
|
Central Nervous System | 1 | 1996 | 151 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 1998 | 388 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 1995 | 43 | 0.030 |
Why?
|
Culture Media | 1 | 1995 | 146 | 0.030 |
Why?
|
Kinetics | 1 | 2018 | 1513 | 0.030 |
Why?
|
Breast | 1 | 2017 | 286 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1992 | 173 | 0.030 |
Why?
|
Actins | 1 | 2018 | 448 | 0.030 |
Why?
|
Lipoxygenase | 3 | 1990 | 8 | 0.030 |
Why?
|
Glutathione Peroxidase | 3 | 1990 | 24 | 0.030 |
Why?
|
Injections | 1 | 2014 | 109 | 0.030 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2014 | 6 | 0.030 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2014 | 26 | 0.030 |
Why?
|
Signal-To-Noise Ratio | 1 | 2014 | 94 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 56 | 0.030 |
Why?
|
Quinoxalines | 1 | 2014 | 50 | 0.030 |
Why?
|
Perfusion | 1 | 2014 | 202 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2014 | 124 | 0.030 |
Why?
|
Genes | 3 | 1989 | 305 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2014 | 261 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2018 | 694 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 262 | 0.030 |
Why?
|
Cytokines | 1 | 2017 | 775 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 321 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1996 | 622 | 0.030 |
Why?
|
Transfection | 2 | 1991 | 895 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2017 | 1135 | 0.030 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1992 | 89 | 0.030 |
Why?
|
Sulfonamides | 1 | 2014 | 299 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2015 | 530 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1992 | 148 | 0.030 |
Why?
|
eIF-2 Kinase | 1 | 2011 | 46 | 0.030 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1991 | 29 | 0.030 |
Why?
|
Glutathione | 1 | 2011 | 103 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2011 | 46 | 0.030 |
Why?
|
Computer Simulation | 1 | 2016 | 1077 | 0.020 |
Why?
|
G1 Phase | 1 | 2011 | 63 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 314 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1991 | 279 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1992 | 302 | 0.020 |
Why?
|
Fetal Death | 2 | 2001 | 56 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 1992 | 266 | 0.020 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 250 | 0.020 |
Why?
|
Tumor Burden | 1 | 2011 | 288 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 1994 | 535 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 547 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 266 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2019 | 6481 | 0.020 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 1988 | 35 | 0.020 |
Why?
|
Pseudogenes | 1 | 1988 | 35 | 0.020 |
Why?
|
Hemagglutinins | 1 | 2008 | 19 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2008 | 83 | 0.020 |
Why?
|
Autophagy-Related Protein 8 Family | 1 | 2007 | 2 | 0.020 |
Why?
|
Omentum | 1 | 2008 | 71 | 0.020 |
Why?
|
Transgenes | 1 | 2008 | 180 | 0.020 |
Why?
|
Permeability | 1 | 2007 | 133 | 0.020 |
Why?
|
Plants | 1 | 2007 | 111 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 2007 | 117 | 0.020 |
Why?
|
Erythropoietin | 1 | 2007 | 91 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1988 | 211 | 0.020 |
Why?
|
DNA | 1 | 1991 | 1293 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2007 | 371 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2007 | 276 | 0.020 |
Why?
|
Rats | 1 | 2011 | 3984 | 0.020 |
Why?
|
Aged | 1 | 2019 | 18353 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2001 | 71 | 0.010 |
Why?
|
Middle Aged | 1 | 2019 | 24957 | 0.010 |
Why?
|
Adult | 1 | 2019 | 25577 | 0.010 |
Why?
|
Gestational Age | 1 | 2001 | 310 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2001 | 509 | 0.010 |
Why?
|
Transcription Factor DP1 | 1 | 1998 | 5 | 0.010 |
Why?
|
Retinoblastoma-Binding Protein 1 | 1 | 1998 | 10 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 1998 | 171 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1998 | 448 | 0.010 |
Why?
|
Quail | 1 | 1994 | 8 | 0.010 |
Why?
|
PAX6 Transcription Factor | 1 | 1994 | 10 | 0.010 |
Why?
|
Pregnancy | 1 | 2001 | 2885 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 1994 | 25 | 0.010 |
Why?
|
Paired Box Transcription Factors | 1 | 1994 | 50 | 0.010 |
Why?
|
Genotype | 1 | 1998 | 1850 | 0.010 |
Why?
|
Eye Proteins | 1 | 1994 | 128 | 0.010 |
Why?
|
Lung | 1 | 1998 | 1167 | 0.010 |
Why?
|
Repressor Proteins | 1 | 1994 | 403 | 0.010 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 1989 | 4 | 0.010 |
Why?
|
Porphyrias | 1 | 1988 | 1 | 0.010 |
Why?
|
Chickens | 1 | 1989 | 212 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1988 | 245 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1988 | 147 | 0.010 |
Why?
|
Plasmids | 1 | 1989 | 287 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1988 | 646 | 0.000 |
Why?
|
Acute Disease | 1 | 1988 | 824 | 0.000 |
Why?
|
Rabbits | 1 | 1988 | 636 | 0.000 |
Why?
|
Chromosome Mapping | 1 | 1988 | 1074 | 0.000 |
Why?
|
Biological Evolution | 1 | 1988 | 917 | 0.000 |
Why?
|